Literature DB >> 1941830

The misdiagnosis of gout and hyperuricemia.

F Wolfe1, M A Cathey.   

Abstract

Of 9,108 consecutive new patients seen in an outpatient rheumatology clinic, 155 (1.7%) were diagnosed as having gout. But 164 (1.8%) had been incorrectly diagnosed as having gout in the community. Misdiagnosis was more likely in those with psoriatic arthritis (odds ratio 3.841, 1.944-7.590) and pseudogout (odds ratio 4.152, 2.422-7.119) and less common in patients with nonspecific arthralgias (odds ratio 0.536, 0.326-0.881). Seventy-six percent of incorrectly diagnosed patients received allopurinol while slightly more than 15% were treated with uricosuric agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941830

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Repeated synovial fluid analysis may be needed to find crystals in gout.

Authors:  R Mader
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

2.  [Screening and early diagnosis of psoriasis arthritis].

Authors:  P Härle
Journal:  Z Rheumatol       Date:  2013-10       Impact factor: 1.372

3.  Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.

Authors:  F Perez-Ruiz; A Alonso-Ruiz; M Calabozo; A Herrero-Beites; G García-Erauskin; E Ruiz-Lucea
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

4.  Foot problems in people with gout in primary care: baseline findings from a prospective cohort study.

Authors:  Edward Roddy; Sara Muller; Keith Rome; Priyanka Chandratre; Samantha L Hider; Jane Richardson; Milisa Blagojevic-Bucknall; Christian D Mallen
Journal:  J Foot Ankle Res       Date:  2015-07-23       Impact factor: 2.303

5.  The association of gout with sleep disorders: a cross-sectional study in primary care.

Authors:  Edward Roddy; Sara Muller; Richard Hayward; Christian D Mallen
Journal:  BMC Musculoskelet Disord       Date:  2013-04-04       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.